Evaluation of novel CDK4/6/9 inhibitors in triple negative breast cancer
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
SPV Therapeutics, Inc
Start Date
June 9, 2020
End Date
December 7, 2020
Administered By
Pharmacology & Cancer Biology
Awarded By
SPV Therapeutics, Inc
Start Date
June 9, 2020
End Date
December 7, 2020